Tempest Therapeutics
(NASDAQ) TPST
Tempest Therapeutics Financials at a Glance
Market Cap
$18.80M
Revenue (TTM)
$0.00
Net Income (TTM)
-$43.10M
EPS (TTM)
-$6.21
P/E Ratio
-0.20
Dividend
$0.00
Beta (Volatility)
1.65 (High)
Dividend
$0.00
Beta (Volatility)
1.65 (High)
Price
$1.26
Volume
71,779.432
Open
$1.24
Price
$1.26
Volume
71,779.432
Open
$1.24
Previous Close
$1.27
Daily Range
$1.24 - $1.29
52-Week Range
$1.23 - $12.23
Estimated Earnings Date
Aug 10, 2026
Dividend
$0.00
Beta (Volatility)
1.65 (High)
Price
$1.26
Volume
71,779.432
Open
$1.24
Previous Close
$1.27
Daily Range
$1.24 - $1.29
52-Week Range
$1.23 - $12.23
Estimated Earnings Date
Aug 10, 2026
TPST News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Tempest Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
4
CEO
Matthew Angel, Ph.D
Website
www.tempesttx.comHeadquarters
Brisbane, CA 94080, US
TPST Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-721%
Return on Capital
-6%
Return on Assets
-4%
Earnings Yield
-5.00%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$18.80M
Shares Outstanding
14.81M
Volume
71.78K
Avg. Volume
205.45K
Financials (TTM)
Gross Profit
$0.00
Operating Income
-$26.58M
EBITDA
-$25.79M
Operating Cash Flow
-$26.82M
Capital Expenditure
$0.00
Free Cash Flow
-$26.82M
Cash & ST Invst.
$7.71M
Total Debt
$8.14M
Tempest Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
-$22.18M
N/A
Gross Margin
0.00%
N/A
Market Cap
$18.80M
N/A
Market Cap/Employee
$783.54K
N/A
Employees
24
N/A
Net Income
-$27.70M
-155.0%
EBITDA
-$27.72M
-160.7%
Quarterly Fundamentals
Net Cash
-$6.05M
-172.0%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$6.62M
-15.8%
Short Term Debt
$1.24M
-76.4%
Return on Assets
-4.01%
N/A
Return on Invested Capital
-5.83%
N/A
Free Cash Flow
-$7.60M
+5.5%
Operating Cash Flow
-$7.60M
+5.5%